Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by Scorpio2on Aug 01, 2020 10:11am
303 Views
Post# 31353540

Questions relating to Warrants

Questions relating to WarrantsI have 2 questions for the board where someone may have some past experience with how this has been handled in other situations.

First, I'm am just trying to better understand how a buyout of a company might be handled differently between the issued common shares and warrants of a company. For an investor to partake in the offered buyout, would they have to convert their warrants first into common shares before being able to take advantage of a buyout or are there typically two different buyout prices for holders of the common shares and a discounted price for the warrant holders before tendering? Just trying to understand how this works in practice.

A separate question I have is if one were to hold warrants in a TFSA. If one were to convert the warrant into common stock in 2020 in your TFSA, it is my belief that the warrant exercise price would then have to be taken into consideration when calculating compliance with the TFSA maximum contribution limit for 2020. For example, if you exercised 20,000 warrants in 2020 at $0.30, that would equate to an additional TFSA contribution of $6,000 for 2020. If you had made an earlier TFSA contribution of $2,000 in 2020, you would then be over the limit. If you made no TFSA contribution earlier in 2020, you would be under the limit.  Is my understanding correct? 
<< Previous
Bullboard Posts
Next >>